Research-centric peptide and protocol reference hub
### Summary MK-677, also known as Ibutamoren, is a growth hormone secretagogue that has garnered attention for its potential effects on muscle mass and body composition. Research is ongoing to better understand its mechanisms and applications in various contexts, including its detection in biological samples.
Aggregate AI baseline blended with community voting. Hover to inspect effect strengths per category.
Effect scores blend an AI baseline with community votes. Open the full chart to see sliders and vote on each category.
Compact view of how logs describe shifts in pain, sleep, and performance (−5 to +5). Treat this as qualitative, anonymous signal only.
No community research logs yet. When structured logs are added, this panel will summarize typical shifts in pain, sleep, and performance.
Rough heatmap of anonymous side-effect and positive-signal tags — a "most-mentioned" snapshot, not safety or efficacy advice.
No anonymous side-effect reports yet. When reports are submitted, this panel will show a simple heatmap of tags like "nausea", "flushing", "improved healing", and more.
Studies, clinical trials, community discussions, and news.
The study investigated the effects of MK-677 (Ibutamoren) on IGF-1 levels in patients with end-stage renal disease (ESRD). The specific dose and duration of treatment were not reported in the abstract. The findings regarding IGF-1 levels were not detailed.
This study evaluated the efficacy and safety of daily oral LUM-201 in prepubertal children with growth hormone deficiency (GHD). The study was randomized, double-blind, and placebo-controlled, spanning 12 months. No therapeutic claims are made regarding the outcomes.
This pilot study evaluated the impact of Ibutamoren on nonalcoholic fatty liver disease (NAFLD). The study's population, dosage, and specific outcomes are not detailed in the abstract. No therapeutic claims are made.
This study evaluated the safety and efficacy of MK-0677 (25 mg) in slowing the progression of Alzheimer's disease. The trial was randomized, double-blind, and placebo-controlled. Not reported in abstract.
This study investigated the effects of MK-677 on lean body mass in subjects with chronic kidney disease (CKD) stages 4 and 5. The study was a phase 2, randomized, double-blind, placebo-controlled trial. Not reported in abstract.
This study evaluated the effects of MK-677, an oral GH secretagogue, on body composition and functional ability in older adults. The specific doses and outcomes measured were not detailed in the abstract. The findings suggest potential changes in body composition and function, but no therapeutic claims are made.
Not reported in abstract.
Not reported in abstract.
MK-677 was detected in equine hair at concentrations of 0.5 to 2.5 ng/mg after oral administration, but the clinical implications of these findings are not established.
Not reported in abstract.
Helpful external resources for additional structural, pharmacologic, and literature context. These are third-party databases; always cross-check details with primary research.
No comments yet. Share research notes, citations, or observations below.
No community research logs yet. Use the “Contribute data” button above to share an anonymized summary of your experience.
This section describes how anonymous side-effect reports are aggregated into the heatmap above. Reports are anonymous and unverified, and should be read alongside primary safety data.
Use the "Report side effects" button to open a focused popup form. Please keep descriptions neutral and avoid medical language; think in terms of "nausea", "flushing", "vivid dreams", etc.
Every time the Librarian touches this peptide — discovering, refreshing, scoring, or verifying — it logs the action here.
Refreshed content for MK-677 (Ibutamoren)
Refreshed content for MK-677 (Ibutamoren)
Completed task: Find real articles for MK-677 (Ibutamoren) (thin literature)
Searched for real articles on MK-677 (Ibutamoren)
Refreshed content for MK-677 (Ibutamoren)
Auto-summarized study: "Semantic Scholar search for MK-677 (Ibutamoren)..."